Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Orphan-paediatric
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Therapy areas
Orphan-paediatric
Orphan-paediatric
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan-paediatric
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 Swiss Stock Exchange:RO
Globenewswire News
-
February 26, 2021
Orphan-paediatric
Dynacure Recognizes Rare Disease Day 2021
Orphan-paediatric
Medivir AB – Year-end Report January – December 2020
Orphan-paediatric
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update Nasdaq:TCON
Orphan-paediatric
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration – FirstWord Pharma
Orphan-paediatric
RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences...
Globenewswire News
-
January 8, 2021
0
Orphan-paediatric
Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common...
Biospace News
-
January 8, 2021
0
Orphan-paediatric
Almirall and Tyris Therapeutics enter into strategic partnership to develop next...
-
January 7, 2021
0
Orphan-paediatric
Aquestive Therapeutics Provides Business Update Nasdaq:AQST
Globenewswire News
-
January 7, 2021
0
Orphan-paediatric
Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting...
-
December 22, 2020
0
1
2
3
...
21
Page 1 of 21
- Advertisement -
MOST POPULAR
Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox...
January 29, 2020
Senate Committees Advance Prescription Price Lowering Bills
June 28, 2019
Cincinnati Startup Raises $50 Million to Advance Hypertension Treatment Licensed from...
May 15, 2019
Roche’s Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast...
March 8, 2019
Load more
HOT NEWS
Commercial
Neos Therapeutics to Host First Quarter 2019 Financial and Operating Results...
Clinical
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the...
Deals
Knight Partners With Debiopharm for the Commercialization of Trelstar in Canada
Clinical
Espero BioPharma Announces Tecarfarin Receives FDA Orphan Drug Designation for Patients...
